Europe Vaccines Market Research Report Forecast 2017-2021

March 2017 | 108 pages | ID: E9F6A06C98FEN
S&P Consulting

Abstracts

The Europe Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Vaccines Market Analysis by Countries:

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

The Major players reported in the market include:
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Abbott
Pfizer
Mitsubishi Tanabe Pharma
LG Life Sciences
Europe Vaccines Market Analysis by Product:
Mono Vaccines
Combination Vaccines
Type 3
Europe Vaccines Market Analysis by Application:
Application 1
Application 2
Application 3

REASONS FOR BUYING THIS REPORT

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Europe Vaccines Sales Market Report Forecast 2017-2021

1 VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Vaccines
1.2 Classification of Vaccines
  1.2.1 Mono Vaccines
  1.2.2 Combination Vaccines
  1.2.3 Type
1.3 Application of Vaccines
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Vaccines Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Vaccines (2012-2021)
  1.5.1 Europe Vaccines Sales and Growth Rate (2012-2021)
  1.5.2 Europe Vaccines Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON VACCINES INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 VACCINES MANUFACTURING COST ANALYSIS

3.1 Vaccines Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Vaccines

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Vaccines Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Vaccines Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE VACCINES MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Vaccines Market Competition by Manufacturers
  5.1.1 Europe Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Vaccines Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Vaccines (Volume and Value) by Type
  5.2.1 Europe Vaccines Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Europe Vaccines (Volume and Value) by Countries
  5.3.1 Europe Vaccines Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Vaccines Revenue and Market Share by Countries (2012-2017)
5.4 Europe Vaccines (Volume) by Application

6 GERMANY VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Vaccines Sales and Value (2012-2017)
  6.1.1 Germany Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 Germany Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Vaccines Sales Price Trend (2012-2017)
6.2 Germany Vaccines Sales and Market Share by Manufacturers
6.3 Germany Vaccines Sales and Market Share by Type
6.4 Germany Vaccines Sales and Market Share by Application

7 FRANCE VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 France Vaccines Sales and Value (2012-2017)
  7.1.1 France Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 France Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 France Vaccines Sales Price Trend (2012-2017)
7.2 France Vaccines Sales and Market Share by Manufacturers
7.3 France Vaccines Sales and Market Share by Type
7.4 France Vaccines Sales and Market Share by Application

8 UK VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 UK Vaccines Sales and Value (2012-2017)
  8.1.1 UK Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 UK Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 UK Vaccines Sales Price Trend (2012-2017)
8.2 UK Vaccines Sales and Market Share by Manufacturers
8.3 UK Vaccines Sales and Market Share by Type
8.4 UK Vaccines Sales and Market Share by Application

9 RUSSIA VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Vaccines Sales and Value (2012-2017)
  9.1.1 Russia Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Russia Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Vaccines Sales Price Trend (2012-2017)
9.2 Russia Vaccines Sales and Market Share by Manufacturers
9.3 Russia Vaccines Sales and Market Share by Type
9.4 Russia Vaccines Sales and Market Share by Application

10 ITALY VACCINES (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Vaccines Sales and Value (2012-2017)
  10.1.1 Italy Vaccines Sales and Growth Rate (2012-2017)
  10.1.2 Italy Vaccines Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Vaccines Sales Price Trend (2012-2017)
10.2 Italy Vaccines Sales and Market Share by Manufacturers
10.3 Italy Vaccines Sales and Market Share by Type
10.4 Italy Vaccines Sales and Market Share by Application

11 SPAIN VACCINES (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Vaccines Sales and Value (2012-2017)
  11.1.1 Spain Vaccines Sales and Growth Rate (2012-2017)
  11.1.2 Spain Vaccines Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Vaccines Sales Price Trend (2012-2017)
11.2 Spain Vaccines Sales and Market Share by Manufacturers
11.3 Spain Vaccines Sales and Market Share by Type
11.4 Spain Vaccines Sales and Market Share by Application

12 BENELUX VACCINES (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Vaccines Sales and Value (2012-2017)
  12.1.1 Benelux Vaccines Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Vaccines Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Vaccines Sales Price Trend (2012-2017)
12.2 Benelux Vaccines Sales and Market Share by Manufacturers
12.3 Benelux Vaccines Sales and Market Share by Type
12.4 Benelux Vaccines Sales and Market Share by Application

13 EUROPE VACCINES MANUFACTURERS ANALYSIS

13.1 GlaxoSmithKline
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Merck
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Pfizer
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Sanofi
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 AstraZeneca
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Abbott
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Pfizer
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Mitsubishi Tanabe Pharma
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 LG Life Sciences
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE VACCINES MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Vaccines Market Forecast by Type (2017-2021)
15.9 Europe Vaccines Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Vaccines
Table Classification of Vaccines
Figure Europe Sales Market Share of Vaccines by Type in 2015
Table Application of Vaccines
Figure Europe Sales Market Share of Vaccines by Application in 2015
Figure Germany Vaccines Revenue and Growth Rate (2012-2021)
Figure France Vaccines Revenue and Growth Rate (2012-2021)
Figure UK Vaccines Revenue and Growth Rate (2012-2021)
Figure Russia Vaccines Revenue and Growth Rate (2012-2021)
Figure Italy Vaccines Revenue and Growth Rate (2012-2021)
Figure Spain Vaccines Revenue and Growth Rate (2012-2021)
Figure Benelux Vaccines Revenue and Growth Rate (2012-2021)
Figure Europe Vaccines Sales and Growth Rate (2012-2021)
Figure Europe Vaccines Revenue and Growth Rate (2012-2021)
Table Europe Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Vaccines Sales Share by Manufacturers
Figure 2016 Vaccines Sales Share by Manufacturers
Table Europe Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Vaccines Revenue Share by Manufacturers
Table 2016 Europe Vaccines Revenue Share by Manufacturers
Table Europe Vaccines Sales and Market Share by Type (2012-2017)
Table Europe Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Vaccines by Type (2012-2017)
Figure Europe Vaccines Sales Growth Rate by Type (2012-2017)
Table Europe Vaccines Revenue and Market Share by Type (2012-2017)
Table Europe Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Vaccines by Type (2012-2017)
Figure Europe Vaccines Revenue Growth Rate by Type (2012-2017)
Table Europe Vaccines Sales and Market Share by Countries (2012-2017)
Table Europe Vaccines Sales Share by Countries (2012-2017)
Figure Sales Market Share of Vaccines by Countries (2012-2017)
Table Europe Vaccines Revenue and Market Share by Countries (2012-2017)
Table Europe Vaccines Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Vaccines by Countries (2012-2017)
Table Europe Vaccines Sales and Market Share by Application (2012-2017)
Table Europe Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Vaccines by Application (2012-2017)
Figure Germany Vaccines Sales and Growth Rate (2012-2017)
Figure Germany Vaccines Revenue and Growth Rate (2012-2017)
Figure Germany Vaccines Sales Price Trend (2012-2017)
Table Germany Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Vaccines Sales by Type (2015 and 2016)
Table Germany Vaccines Market Share by Type (2015 and 2016)
Table Germany Vaccines Sales by Application (2015 and 2016)
Table Germany Vaccines Market Share by Application (2015 and 2016)
Figure France Vaccines Sales and Growth Rate (2012-2017)
Figure France Vaccines Revenue and Growth Rate (2012-2017)
Figure France Vaccines Sales Price Trend (2012-2017)
Table France Vaccines Sales by Manufacturers (2015 and 2016)
Table France Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Vaccines Sales by Type (2015 and 2016)
Table France Vaccines Market Share by Type (2015 and 2016)
Table France Vaccines Sales by Application (2015 and 2016)
Table France Vaccines Market Share by Application (2015 and 2016)
Figure UK Vaccines Sales and Growth Rate (2012-2017)
Figure UK Vaccines Revenue and Growth Rate (2012-2017)
Figure UK Vaccines Sales Price Trend (2012-2017)
Table UK Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Vaccines Sales by Type (2015 and 2016)
Table UK Vaccines Market Share by Type (2015 and 2016)
Table UK Vaccines Sales by Application (2015 and 2016)
Table UK Vaccines Market Share by Application (2015 and 2016)
Figure Russia Vaccines Sales and Growth Rate (2012-2017)
Figure Russia Vaccines Revenue and Growth Rate (2012-2017)
Figure Russia Vaccines Sales Price Trend (2012-2017)
Table Russia Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Vaccines Sales by Type (2015 and 2016)
Table Russia Vaccines Market Share by Type (2015 and 2016)
Table Russia Vaccines Sales by Application (2015 and 2016)
Table Russia Vaccines Market Share by Application (2015 and 2016)
Figure Italy Vaccines Sales and Growth Rate (2012-2017)
Figure Italy Vaccines Revenue and Growth Rate (2012-2017)
Figure Italy Vaccines Sales Price Trend (2012-2017)
Table Italy Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Vaccines Sales by Type (2015 and 2016)
Table Italy Vaccines Market Share by Type (2015 and 2016)
Table Italy Vaccines Sales by Application (2015 and 2016)
Table Italy Vaccines Market Share by Application (2015 and 2016)
Figure Spain Vaccines Sales and Growth Rate (2012-2017)
Figure Spain Vaccines Revenue and Growth Rate (2012-2017)
Figure Spain Vaccines Sales Price Trend (2012-2017)
Table Spain Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Vaccines Sales by Type (2015 and 2016)
Table Spain Vaccines Market Share by Type (2015 and 2016)
Table Spain Vaccines Sales by Application (2015 and 2016)
Table Spain Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Vaccines Sales and Growth Rate (2012-2017)
Figure Benelux Vaccines Revenue and Growth Rate (2012-2017)
Figure Benelux Vaccines Sales Price Trend (2012-2017)
Table Benelux Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Vaccines Sales by Type (2015 and 2016)
Table Benelux Vaccines Market Share by Type (2015 and 2016)
Table Benelux Vaccines Sales by Application (2015 and 2016)
Table Benelux Vaccines Market Share by Application (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Vaccines Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Vaccines Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Vaccines Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Vaccines Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Vaccines Sales Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Vaccines Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Vaccines Sales Market Share (2012-2017)
Table Mitsubishi Tanabe Pharma Basic Information List
Table Mitsubishi Tanabe Pharma Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mitsubishi Tanabe Pharma Vaccines Sales Market Share (2012-2017)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure LG Life Sciences Vaccines Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vaccines
Figure Manufacturing Process Analysis of Vaccines
Figure Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Vaccines Major Manufacturers in 2015
Table Major Buyers of Vaccines
Table Distributors/Traders List
Figure Germany Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Germany Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure France Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure France Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure UK Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure UK Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Russia Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Italy Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Spain Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table Europe Vaccines Sales Forecast by Type (2017-2021)
Table Europe Vaccines Sales Forecast by Application (2017-2021)